bannerHON
img
HONnews
HONnews
img PATIENT / PARTICULIER img PROFESSIONNEL DE SANTE img WEBMESTRE img
img
 
img
HONcode sites
Khresmoi - new !
HONselect
News
Conferences
Images

Themes:
A B C D E F G H I
J K L M N O P Q
R S T U V W X Y Z
Browse archive:
2014: N O S A J J M A M F J
2013: D N

  Statins Don't Prevent Kidney Disease Progression, Study Finds
But the drugs do help lower cholesterol in these patients, researchers say

By Randy Dotinga

THURSDAY, May 1, 2014 (HealthDay News) -- The cholesterol-lowering medications known as statins won't help people with kidney disease avoid dialysis, but the drugs do lower cholesterol in this group, researchers have found.

"Statins had no effect -- neither good nor bad -- on kidney function," study author Dr. Richard Haynes, of the University of Oxford in England, said in an American Society of Nephrology news release.

The study included over 6,000 patients with chronic kidney disease who didn't yet need dialysis, a process in which a machine does some of the kidney's blood-filtering tasks. About 60 million people worldwide have chronic kidney disease, according to background information in the news release.

People in the study randomly received either the cholesterol-lowering medication Vytorin, which is a combination of simvastatin plus the drug ezetimibe, or an inactive placebo.

The researchers followed the patients for five years. The drug combination lowered LDL cholesterol -- the bad type -- by an average of approximately 39 milligrams per deciliter compared to the placebo. But, it didn't affect the need for dialysis or kidney transplants in the study volunteers: about 34 percent in each group needed those treatments.

The study also confirmed that the drugs are safe for people with kidney disease to take. And, the authors noted, the drug's cholesterol-lowering properties help reduce the risk of heart disease and stroke.

Results of the study were published online May 1 in the Journal of the American Society of Nephrology. The study's main funder was Merck/Schering-Plough Pharmaceuticals, which makes Vytorin.

More information

For more about kidney disease, go to the National Kidney Foundation.

SOURCE: American Society of Nephrology, news release, May 1, 2014

Copyright © 2014 HealthDay. All rights reserved. URL:http://consumer.healthday.com/Article.asp?AID=687325

Resources from HONselect: HONselect is the HON's medical search engine. It retrieves scientific articles, images, conferences and web sites on the selected subject.
Kidney
Kidney Diseases
Disease Progression
Research Personnel
Specialty Chemicals and Products
Dialysis
Cholesterol
Transplants
Affect
Heart
The list of medical terms above are retrieved automatically from the article.

Disclaimer: The text presented on this page is not a substitute for professional medical advice. It is for your information only and may not represent your true individual medical situation. Do not hesitate to consult your healthcare provider if you have any questions or concerns. Do not use this information to diagnose or treat a health problem or disease without consulting a qualified healthcare professional.
Be advised that HealthDay articles are derived from various sources and may not reflect your own country regulations. The Health On the Net Foundation does not endorse opinions, products, or services that may appear in HealthDay articles.


Home img About us img MediaCorner img HON newsletter img Site map img Ethical policies img Contact